Literature DB >> 14994235

An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers.

Jordana Segal1, Mary Jane Esplen, Brenda Toner, Sylvia Baedorf, Steven Narod, Kate Butler.   

Abstract

Disclosure of the results of a positive genetic mutation to offspring can be challenging. The purpose of this study was to investigate the content and process of disclosure from BRCA1/2 carriers to their offspring. A semi-structured questionnaire focused on the disclosure processes between parent and offspring. Thirty-one/40 mothers with BRCA1/2 mutations completed the cross-sectional survey. Sixteen carriers (51.6%) chose to disclose their results to all of their children, thirteen carriers (41.9%) chose not to disclose their results, and two carriers (6.5%) chose to disclose to some of their children. The age of a child appeared to be the most significant contributing factor in the decision to disclose. The mean age of the offspring who learned of the positive test result was 24.3 years with most carriers advocating the ideal age range for disclosure from 19 to 25 years. There was a discrepancy between actual and potential disclosure topics between those who had disclosed and those who had not disclosed at the time of the survey. Women who disclosed their result tended to do so alone, within a week of learning their own results, equally to male and female offspring and expressed that the relationships between themselves and their children had strengthened since revealing the presence of a genetic mutation in the family. Women who had not disclosed the results of their genetic test to offspring were significantly more interested in receiving additional individual counseling, educational videos, and email newsletters that focus on disclosure of this complex and life altering information compared to those who had already disclosed. Disclosure of BRCA1/2 results is determined primarily by age of offspring, is usually done by women alone, relatively soon after receiving results and appears to enhance the relationships between mothers and offspring. Both disclosed and non-disclosed carriers demonstrated significant interest in a variety of interventions to support the disclosure process. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14994235     DOI: 10.1002/ajmg.a.20485

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  24 in total

1.  Stigmatization and male identity: Norwegian males' experience after identification as BRCA1/2 mutation carriers.

Authors:  Nina Strømsvik; Målfrid Råheim; Nina Oyen; Lars Fredrik Engebretsen; Eva Gjengedal
Journal:  J Genet Couns       Date:  2010-03-20       Impact factor: 2.537

2.  Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder.

Authors:  G K Suthers; J Armstrong; J McCormack; D Trott
Journal:  J Med Genet       Date:  2005-12-21       Impact factor: 6.318

3.  An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.

Authors:  Paboda Ratnayake; Claire E Wakefield; Bettina Meiser; Graeme Suthers; Melanie A Price; Jessica Duffy; Kathy Tucker
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

4.  Sources of uncertainty about daughters' breast cancer risk that emerge during genetic counseling consultations.

Authors:  Carma L Bylund; Carla L Fisher; Dale Brashers; Shawna Edgerson; Emily A Glogowski; Sherry R Boyar; Yelena Kemel; Sara Spencer; David Kissane
Journal:  J Genet Couns       Date:  2011-08-11       Impact factor: 2.537

5.  Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease.

Authors:  Sato Ashida; Laura M Koehly; J Scott Roberts; Clara A Chen; Susan Hiraki; Robert C Green
Journal:  J Health Commun       Date:  2009-12

6.  What women with breast cancer discuss with clinicians about risk for their adolescent daughters.

Authors:  Erin Maloney; Shawna Edgerson; Mark Robson; Ken Offit; Richard Brown; Carma Bylund; David W Kissane
Journal:  J Psychosoc Oncol       Date:  2012

7.  "I Don't Want to Be an Ostrich": Managing Mothers' Uncertainty during BRCA1/2 Genetic Counseling.

Authors:  Carla L Fisher; Thomas Roccotagliata; Camella J Rising; David W Kissane; Emily A Glogowski; Carma L Bylund
Journal:  J Genet Couns       Date:  2016-07-30       Impact factor: 2.537

8.  Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice.

Authors:  Andrea Farkas Patenaude; Tiffani A DeMarco; Beth N Peshkin; Heiddis Valdimarsdottir; Judy E Garber; Katherine A Schneider; Larissa Hewitt; Jennifer Hamilton; Kenneth P Tercyak
Journal:  J Genet Couns       Date:  2012-10-24       Impact factor: 2.537

9.  Role of parenting relationship quality in communicating about maternal BRCA1/2 genetic test results with children.

Authors:  Tiffani A DeMarco; Beth N Peshkin; Heiddis B Valdimarsdottir; Andrea F Patenaude; Katherine A Schneider; Kenneth P Tercyak
Journal:  J Genet Couns       Date:  2008-02-21       Impact factor: 2.537

10.  A family genetic risk communication framework: guiding tool development in genetics health services.

Authors:  Miriam E Wiens; Brenda J Wilson; Christina Honeywell; Holly Etchegary
Journal:  J Community Genet       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.